Tissue factor in atherosclerosis

Atherosclerosis

Volumn 144, Issue 2, 1999, Pages 273-283

  Tremoli, Elena ^a   Camera, Marina ^a   Toschi, Vincenzo ^b   Colli, Susanna ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN CARLO BORROMEO HOSPITAL   (Italy)

Author keywords

Acute coronary syndromes; Atheroma; Atherosclerosis; Plaque cellularity; Plaque thrombogenicity; Thrombosis; Tissue factor

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DERIVATIVE; CYCLOSPORIN A; CYTOKINE; DILAZEP; DIPYRIDAMOLE; PROSTACYCLIN DERIVATIVE; STATINE DERIVATIVE; THROMBOPLASTIN;

ATHEROGENESIS; ATHEROMA; ATHEROSCLEROSIS; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REVIEW; THROMBOGENICITY; THROMBOSIS; TISSUE DISTRIBUTION;

ARTERIOSCLEROSIS; CORONARY ARTERIOSCLEROSIS; CORONARY THROMBOSIS; CORONARY VESSELS; HUMANS; THROMBOPLASTIN; THROMBOSIS;

EID: 0032977708     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00063-5     Document Type: Review

References (115)

1. Libby P. Atheroma: more than mush. Lancet. 348:1996;4.
2. Falk E., Shah P., Fuster V. Coronary plaque disruption. Circulation. 92:1995;657.
3. Fuster V., Fallon J.T., Badimon J.J., Nemerson Y. The unstable atherosclerotic plaque: clinical significance and therapeutic intervention. Thromb Haemost. 78:1997;247.
4. Edgington T., Mackman N., Brand K., Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost. 66:1991;67.
5. Carson S.D., Brozna J.P. The role of tissue factor in the production of thrombin. Blood Coagul Fibrinolysis. 4:1993;281.
6. Bugge T.H., Xiao Q., Kombrinck K.W., Flick M.J., Holmback K., Danton M.S., Colbert M.C., Witte D.P., Fujikawa K., Davie E.W., Degen J.L. Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation. Proc Natl Acad Sci USA. 93:1996;6258.
7. Toomey J.R., Kratzer K.E., Lasky N.M., Stanton J.J., Broze G.J. Jr Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood. 88:1996;1583.
8. Carmeliet P., Mackman N., Moons L., Luther T., Gressens P., Van Vlaenderen I., Demunck H., Kasper M., Breier G., Evrard P., Muller M., Risau W., Edgington T., Collen D. Role of tissue factor in embryonic blood vessel development. Nature. 383:1996;73.
9. Drake T.A., Cheng J., Chang A., Taylor F.B. Jr Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal E. coli sepsis. Am J Pathol. 142:1993;1458.
10. Warr T.A., Rao L.V., Rapaport S.I. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. Blood. 75:1990;1481.
11. Taylor F.B. Jr, Chang A., Ruf W., Morrissey J.H., Hinshaw L., Catlett R., Blick K., Edgington T.S. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock. 33:1991;127.
12. Broze G.J. Jr Tissue factor pathway of coagulation: factor VII, tissue factor, and tissue factor pathway inhibitor. Bloom A.L., Forbes C.D., Thomas D.P., Tuddenham E.G.D. 3rd edition Haemostasis and Thrombosis. 2:1994;349 Churchill Livingstone, Singapore.
13. 2+ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize tissue factor. J Biol Chem. 270:1995;4650.
14. Poulsen L.K., Jacobsen N., Sorensen B.B., Bergenhem N.C.H., Kelly J.D., Foster D.C., Thastrup O., Ezban M., Petersen L.C. Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor. J Biol Chem. 273:1998;6228.
15. Drake T.A., Ruf W., Morrissey J.H., Edgington T.S. Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line. J Cell Biol. 109:1989;389.
16. Pernod G., Polack B., Peyron F., Luisy A., Kolodié L., Ambroise-Thomas P., Santoro F. Monocyte tissue factor expression induced by Plasmodium falciparum-infected erythrocytes. Thromb Haemost. 68:1992;111.
17. Teysseire N., Arnoux D., George F., Sampol J., Raoult D. von Willebrand factor release and thrombomodulin and tissue factor expression in Rickettsia conorii-infected endothelial cells. Infect Immun. 60:1992;4388.
18. Celi A., Pellegrini G., Lorenzet R., De Blasi A., Ready N., Furie B.C., Furie B. P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci USA. 91:1994;8767.
19. Palabrica T., Lobb R., Furie B.C., Aronowitz M., Benjamin C., Hsu Y.-M., Sajer S.A., Furie B. Leukocyte accumulation which promotes fibrin deposition is mediated in vivo by P-selectin (CD62) on adherent platelets. Nature. 35:1992;9848.
20. Levy G., Edgington T.S. Lymphocyte cooperation is required for amplification of macrophage procoagulant activity. J Exp Med. 151:1980;1232.
21. Mach F., Schonbeck U., Sukhova G.K., Bourcier T., Bonnefoy J.Y., Pober J.S., Libby P. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci USA. 94:1997;1931.
22. Lyberg T., Galdal K.S., Evensen S.A., Prydz H. Cellular cooperation in endothelial cell thromboplastin synthesis. Br J Hematol. 53:1982;85.
23. Schmid E., Muller T.H., Budzinski R.-M., Pfizenmaier K., Binder K. Lymphocyte adhesion to human endothelial cells induces tissue factor expression via a juxtacrine pathway. Thromb Haemost. 73:1995;421.
24. Geczy C.L. Induction of macrophage procoagulant by products of activated lymphocytes. Haemostasis. 14:1984;400.
25. Carson S.D., Henry W.M., Shows T.B. Tissue factor gene localized to human chromosome 1 (1pter-1p21). Science. 229:1985;991.
26. Mackman N., Morrissey J.H., Fowler B., Edgington T.S. Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade. Biochemistry. 28:1989;1755.
27. Scarpati E.M., Wen D., Broze G. Jr, Miletich J.P., Flandermeyer R.R., Siegel N.R., Sadler J.E. Human tissue factor: cDNA sequence and chromosome localization of the gene. Biochemistry. 26:1987;5234.
28. Oeth P., Parry G.C.N., Mackman N. Regulation of the tissue factor gene in human monocytic cells: role of AP-1, NF-κB/Rel, and Sp1 proteins in uninduced and lipopolysaccharide-induced expression. Arterioscler Thromb Vasc Biol. 17:1997;365.
29. Moll T., Czyz M., Holzmuller H., Hofer-Warbinek R., Wagner E., Winkler H., Bach F.H., Hofer E. Regulation of the tissue factor promoter in endothelial cells. Binding of NF-κB-, AP-1-, and Sp1-like transcription factors. J Biol Chem. 270:1995;3849.
30. Mackman N. Regulation of the tissue factor gene. FASEB J. 9:1995;883.
31. Verma I., Stevenson J., Schwarz E., Van Antwerp D., Miyamoto S. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:1995;2723.
32. Oeth P., Mackman N. Salicylates inhibit lipopolysaccharide-induced transcriptional activation of the tissue factor gene in human monocytic cells. Blood. 86:1995;4144.
33. Mackman N. Protease inhibitors block lipopolysaccharide induction of tissue factor gene expression in human monocytic cells by preventing activation of c-Rel/p65 heterodimers. J Biol Chem. 269:1994;26363.
34. Osnes L.T., Foss K.B., Joo G.B., Okkenhaug C., Westvik A.B., Ovstebo R., Kierulf P. Acetylsalicylic acid and sodium salicylate inhibit LPS-induced NF-κB/c-Rel nuclear translocation, and synthesis of tissue factor (TF) and tumor necrosis factor alfa (TNF-α) in human monocytes. Thromb Haemost. 76:1996;970.
35. Orthner C.L., Rodgers G.M., Fitzgerald L.A. Pyrrolidine dithiocarbamate abrogates tissue factor (TF) expression by endothelial cells: evidence implicating nuclear factor-κB in TF induction by diverse agonists. Blood. 86:1995;436.
36. Wrighton C.J., Hofer-Warbinek R., Moll T., Eytner R., Bach F.H., de Martin R. Inhibition of endothelial cell activation by adenovirus-mediated expression of IκBα, an inhibitor of the transcription factor NF-κB. J Exp Med. 183:1996;1013.
37. Wilcox J.N., Smith K.M., Schwartz S.M., Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA. 86:1989;2839.
38. Drake T.A., Morrissey J.H., Edgington T.S. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol. 134:1989;1087.
39. Thiruvikraman S.V., Guha A., Roboz J., Taubman M.B., Nemerson Y., Fallon J.T. In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X. Lab Invest. 75:1996;451.
40. Levy G.A., Schwartz B.S., Curtiss L.K., Edgington T.S. Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro: requirements for cellular collaboration. J Clin Invest. 67:1981;1614.
41. Tremoli E., Camera M., Maderna P., Sironi L., Prati L., Colli S., Piovella F., Bernini F., Corsini A., Mussoni L. Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs. An LDL receptor-independent phenomenon. Arterioscler Thromb. 13:1993;338.
42. Weis J.R., Pitas R.E., Wilson B.D., Rodgers G.M. Oxidized low-density lipoprotein increases cultured human endothelial cell tissue factor activity and reduces protein C activation. FASEB J. 5:1991;2459.
43. Kaneko T., Wada H., Wakita Y., Minamikawa K., Nakase T., Mori Y., Deguchi K., Shirakawa S. Enhanced tissue factor activity and plasminogen activator inhibitor-1 antigen in human umbilical vein endothelial cells incubated with lipoproteins. Blood Coagul Fibrinolysis. 5:1994;385.
44. Drake T.A., Hannani K., Fei H., Lavi S., Berliner J.A. Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells. Am J Pathol. 138:1991;601.
45. Lewis J.C., Bennett-Cain A.L., DeMars C.S., Doellgast G.J., Grant K.W., Jones N.L., Gupta M. Procoagulant activity after exposure of monocyte-derived macrophages to minimally oxidized low density lipoprotein. Co-localization of tissue factor antigen and nascent fibrin fibers at the cell surface. Am J Pathol. 147:1995;1029.
46. Brand K., Banka C.L., Mackman N., Terkeltaub R.A., Fan S.T., Curtiss L.K. Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes. Arterioscler Thromb. 14:1994;790.
47. Schlichting E., Henriksen T., Lyberg T. Lipoproteins do not modulate the tissue factor activity, plasminogen activator or tumor necrosis factor production induced by lipopolysaccharide stimulation of human monocytes. Scand J Clin Lab Invest. 54:1994;465.
48. Stragliotto E., Maderna P., Bernini F., Tremoli E. Acetyl-LDL but not native and ox-LDL stimulate the expression of procoagulant activity by monocytes. Thromb Haemost. 65:1991;1870. Abstract.
49. Schuff-Werner P., Claus G., Armstrong V.W., Kostering H., Seidel D. Enhanced procoagulatory activity (PCA) of human monocytes/ macrophages after in vitro stimulation with chemically modified LDL. Atherosclerosis. 78:1989;109.
50. Lesnik P., Rouis M., Skarlatos S., Kruth H.S., Chapman M.J. Uptake of exogenous free cholesterol induces upregulation of tissue factor expression in human monocyte-derived macrophages. Proc Natl Acad Sci USA. 89:1992;10370.
51. Colli S., Lalli M., Risè P., Mussoni L., Eligini S., Galli C., Tremoli E. Increased thrombogenic potential of human macrophages spontaneously transformed into foam cells. Thromb Haemost. 81:1999;576.
52. 2+ mobilization and protein kinase C activation. J Clin Invest. 91:1993;547.
53. Schecter A.D., Giesen P.L., Taby O., Rosenfield C.L., Rossikhina M., Fyfe B.S., Kohtz D.S., Fallon J.T., Nemerson Y., Taubman M.B. Tissue factor expression in human arterial smooth muscle cells: TF is present in three cellular pools after growth factor stimulation. J Clin Invest. 100:1997;2276.
54. Camera M., Giesen P.L.A., Fallon J., Aufiero B., Taubman M., Tremoli E., Nemerson Y Cooperation between VEGF and TNFα is necessary for exposure of active tissue factor on the surface of human endothelial cells. Arterioscler Thromb Vasc Biol. 19:1999;531.
55. Pendurthi U.R., Williams J.T., Rao L.V. Acidic and basic fibroblast growth factors suppress transcriptional activation of tissue factor and other inflammatory genes in endothelial cells. Arterioscler Thromb Vasc Biol. 17:1997;940.
56. Mach F., Schonbeck U., Bonnefoy J.Y., Pober J.S., Libby P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation. 96:1997;396.
57. Kato K., Elsayed Y.A., Namoto M., Nakagawa K., Sueishi K. Enhanced expression of tissue factor activity in the atherosclerotic aortas of cholesterol-fed rabbits. Thromb Res. 82:1996;335.
58. Marmur J.D., Rossikhina M., Guha A., Fyfe B., Friedrich V., Mendlowitz M., Nemerson Y., Taubman M.B. Tissue factor is rapidly induced in arterial smooth muscle after balloon injury. J Clin Invest. 91:1993;2253.
59. Taubman M.B., Fallon J.T., Schecter A.D., Giesen P., Mendlowitz M., Fyfe B.S., Marmur J.D., Nemerson Y. Tissue factor in the pathogenenesis of atherosclerosis. Thromb Haemost. 78:1997;200.
60. Harker L.A., Hanson S.R., Kelly A.B. Antithrombotic strategies targeting thrombin activities, thrombin receptors and thrombin generation. Thromb Haemost. 78:1997;736.
61. Jang Y., Guzman L.A., Lincoff A.M., Gottsauner-Wolf M., Forudi F., Hart C.E., Courtman D.W., Ezban M., Ellis S.G., Topol E.J. Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model. Circulation. 92:1995;3041.
62. Oltrona L., Speidel C.M., Recchia D., Wickline S.A., Eisenberg P.R., Abendschein D.R. Inhibition of tissue factor-mediated coagulation markedly attenuates stenosis after ballon-induced arterial injury in minipigs. Circulation. 96:1997;646.
63. Falk E., Fernandez-Ortiz A. Role of thrombosis in atherosclerosis and its complications. Am J Cardiol. 75:1995;3B.
64. Annex B.H., Denning S.M., Channon K.M., Sketch M.H. Jr, Stack R.S., Morrissey J.H., Peters K.G. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation. 91:1995;619.
65. Marmur J.D., Thiruvikraman S.V., Fyfe B.S., Guha A., Sharma S.K., Ambrose J.A., Fallon J.T., Nemerson Y., Taubman M.B. Identification of active tissue factor in human coronary atheroma. Circulation. 94:1996;1226.
66. Ardissino D., Merlini P.A., Ariens R., Coppola R., Bramucci E., Mannucci P.M. Tissue-factor antigen and activity in human coronary atherosclerotic plaques. Lancet. 349:1997;769.
67. Moreno P.R., Bernardi V.H., Lopez-Cuellar J., Murcia A.M., Palacios I.F., Gold H.K., Mehran R., Sharma S.K., Nemerson Y., Fuster V., Fallon J.T. Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation. 94:1996;3090.
68. Kaikita K., Ogawa H., Yasue H., Takeya M., Takahashi K., Saito T., Hayasaki K., Horiuchi K., Takizawa A., Kamikubo Y., Nakamura S. Tissue factor expression on macrophages in coronary plaques in patients with unstable angina. Arterioscler Thromb Vasc Biol. 17:1997;2232.
69. Agraou B., Corseaux D., McFadden E.P., Bauters A., Cosson A., Jude B. Effects of coronary angioplasty on monocyte tissue factor response in patients with stable or unstable angina. Thromb Res. 88:1997;237.
70. Leatham E.W., Bath P.M.W., Tooze J.A., Camm A.J. Increased monocyte tissue factor expression in coronary disease. Br Heart J. 73:1995;10.
71. Neri Serneri G.G., Abbate R., Gori A.M., Attanasio M., Martini F., Giusti B., Dabizzi P., Poggesi L., Modesti P.A., Trotta F., Rostagno C., Boddi M., Gensini G.F. Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation. 86:1992;790.
72. Fernandez-Ortiz A., Badimon J.J., Falk E., Fuster V., Meyer B., Mailhac A., Weng D., Shah P.K., Badimon L. Characterization of the relative thrombogenicity of atherosclerotic plaque components: Implications for consequences of plaque rupture. J Am Coll Cardiol. 23:1994;1562.
73. Toschi V., Gallo R., Lettino M., Fallon J.T., Gertz S.D., Fernandez-Ortiz A., Chesebro J.H., Badimon L., Nemerson Y., Fuster V., Badimon J.J. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation. 95:1997;594.
74. Creasey A.A., Chang A.C.K., Feigen L., Wun T.C., Taylor F.B. Jr, Hinshaw L.B. Tissue factor pathway inhibitor (TFPI) reduces mortality from E. coli septic shock. J Clin Invest. 91:1993;2850.
75. Carr C., Bild G.S., Chang A.C., Peer G.T., Palmier M.O., Frazier R.B., Gustafson M.E., Wun T.C., Creasey A.A., Hinshaw L.B. Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon gram-negative model of septic shock. Circ Shock. 44:1994;126.
76. Sabharwal A.K., Bajaj S.P., Ameri A., Tricomi S.M., Hyers T.M., Dahms T.E., Taylor F.B. Jr, Bajaj M.S. Tissue factor pathway inhibitor and von Willebrand factor antigen levels in adult respiratory distress syndrome and in a primate model of sepsis. Am J Respir Crit Care Med. 151:1995;758.
77. Haskel E.J., Torr S.R., Day K.C., Palmier M.O., Wun T.C., Sobel B.E., Abendschein D.R. Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor. Circulation. 84:1991;821.
78. Pawashe A.B., Golino P., Ambrosio G., Migliaccio F., Ragni M., Pascucci I., Chiariello M., Bach R., Garen A., Konigsberg W.K. A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries. Circ Res. 74:1994;56.
79. Jang I.K., Gold H.K., Leinbach R.C., Fallon J.T., Collen D., Wilcox J.N. Antithrombotic effect of a monoclonal antibody against tissue factor in a rabbit model of platelet-mediated arterial thrombosis. Arterioscler Thromb. 12:1992;948.
80. Sorensen B.B., Persson E., Freskard P.O., Kialke M., Ezban M., Williams T., Rao L.V. Incorporation of an active site inhibitor in factor VIIa alters the affinity for tissue factor. J Biol Chem. 272:1997;16708.
81. Golino P., Ragni M., Cirillo P., D'Andrea D., Scognamiglio A., Ravera A., Buono C., Ezban M., Corcione N., Vigorito F., Condorelli M., Chiariello M. Antithrombotic effects of recombinant human, active site-blocked factor VIIa in a rabbit model of recurrent arterial thrombosis. Circ Res. 82:1998;39.
82. Crutchley D.J., Hirsch M.J. The stable prostacyclin analogue, Iloprost, and prostaglandin E1 inhibit monocyte procoagulant activity in vitro. Blood. 78:1991;382.
83. Hasday J.D., Sitrin R.G. Dipyridamole stimulates urokinase production and suppresses procoagulant activity of rabbit alveolar macrophages: a possible mechanism of antithrombotic action. Blood. 69:1989;660.
84. Colli S., Tremoli E. Multiple effects of dipyridamole on neutrophils and mononuclear leukocytes:adenosine-dependent and adenosine-independent mechanisms. J Lab Clin Med. 118:1991;136.
85. de Prost D. Pentoxifylline:a potential treatment for thrombosis associated with abnormal tissue factor expression by monocytes and endothelial cells. J Cardiovasc Pharmacol. 25:1995;114.
86. Deguchi H., Takeya H., Wada H., Gabazza E.C., Hayashi N., Urano H., Suzuki K. Dilazep, an antiplatelet agent, inhibits tissue factor expression in endothelial cells and monocytes. Blood. 90:1998;2345.
87. Ollivier P., Parry G.C.N., Cobb R.R., de Prost D., Mackman N. Elevated cyclic AMP inhibits NF-κB-mediated transcription in human monocytic cells and endothelial cells. J Biol Chem. 271:1996;20828.
88. Levi M., ten Cate H., Bauer K.A., Van der Poll T., Edgington T.S., Buller H.R., Van Deventer S.J.H., Hack C.E., ten Cate J.W., Rosenberg R.D. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest. 93:1994;114.
89. Bottles K.D., Morrissey J.H. Dexamethasone enhances agonist induction of tissue factor in monocytes but not in endothelial cells. Blood Coagul Fibrinolysis. 4:1993;405.
90. Muhlfelder T.W., Niemetz J., Kang S. Glucocorticoids inhibit the generation of leukocyte procoagulant (tissue factor activity). Blood. 60:1982;1169.
91. Gray E., Thomas S., Mistry Y., Poole S. Inhibition of tissue factor and cytokine release. Haemostasis. 1:1996;92.
92. Holschermann H., Kohl O., Maus U., Durfeld F., Bierhaus A., Nawroth P.P., Lohmeyer J., Tillmans H., Haberbosch W. Cyclosporin A inhibits monocyte tissue factor activation in cardiac transplant recipients. Circulation. 96:1997;4232.
93. Savi P., Bernat A., Dumas A., Ait-Chek L., Herbert J.M. Effect of aspirin and clopidogrel on platelet-dependent tissue factor expression in endothelial cells. Thromb Res. 73:1994;117.
94. Amirkhosravi A., Alexander M., May K., Francis D.A., Warnes G., Biggerstaff J., Francis J.L. The importance of platelets in the expression of monocyte tissue factor antigen measured by a new whole blood flow cytometric assay. Thromb Haemost. 75:1996;87.
95. Herbert J.M., Savi P., Laplace M.C., Lale A. IL-4 inhibits LPS-, IL-1β- and TNFα-induced expression of tissue factor in endothelial cells and monocytes. FEBS Lett. 310:1992;31.
96. Osnes L.T., Westvik A.B., Joo G.B., Okkenhaug C., Kierulf P. Inhibition of IL-1 induced tissue factor (TF) synthesis and procoagulant activity (PCA) in purified human monocytes by IL-4, IL-10 and IL-13. Cytokine. 8:1996;822.
97. Ramani M., Khechai F., Ollivier V., Ternisien C., Bridey F., Hakim J., de Prost D. Interleukin-10 and pentoxifylline inhibit C-reactive protein-induced tissue factor gene expression in peripheral human blood monocytes. FEBS Lett. 356:1994;86.
98. Ernofsson M., Tenno T., Siegbahn A. Inhibition of tissue factor surface expression in human peripheral blood monocytes exposed to cytokines. Br J Haematol. 95:1996;249.
99. Goodnight S.H. Fish oil and vascular disease. Trends Cardiovasc Med. 1:1992;112.
100. Harker L.A., Kelly A.B., Hanson S.R., Krupski W., Bass A., Osterud B., FitzGerald G.A., Goodnight S.H., Connor W.E. Interruption of vascular thrombus formation and vascular lesion formation by dietary n-3 fatty acids in fish oil in non-human primates. Circulation. 87:1993;1017.
101. Tremoli E., Eligini S., Colli S., Maderna P., Rise P., Pazzucconi F., Marangoni F., Sirtori C.R., Galli C. n-3 fatty acid ethyl ester administration to healthy subjects and to hypertriglyceridemic patients reduces tissue factor activity in adherent monocytes. Arterioscler Thromb. 14:1994;1600.
102. Endres S., Ghorbani R., Kelly V.E., Georgilis K., Lonnemann G., van der Meer J.W., Cannon J.G., Rogers T.S., Klempner M.S., Weber P.C. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. New Engl J Med. 320:1989;265.
103. Nishimura H., Tsuji H., Masuda H., Nakagawa K., Nakahara Y., Kitamura H., Kasahara T., Sugano T., Yoshizumi M., Sawada S., Nakagawa M. Angiotensin II increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells. Thromb Haemost. 77:1997;1189.
104. Napoleone E., Di Santo A., Lorenzet R. The renin-angiotensin system and modulation of monocyte tissue factor activity. Thromb Haemost. 78:1997;1498. Abstract.
105. Grundy S.M. HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. New Engl J Med. 319:1988;24.
106. Sirtori C.R. Tissue selectivity of hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors. Pharmacol Ther. 60:1993;431.
107. Anon A. Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S). Lancet. 345:1995;1274.
108. Corsini A., Mazzotti M., Raiteri M., Soma M.R., Gabbiani G., Fumagalli R., Paoletti R. Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase. Atherosclerosis. 101:1993;117.
109. Soma M.R., Donetti E., Parolini C., Mazzini G., Ferrari C., Fumagalli R., Paoletti R. HMG CoA reductase inhibitors: in vivo effects on carotid intimal thickening in normocholesterolemic rabbits. Arterioscler Thromb. 13:1993;571.
110. Kempen H.J., Vermeer M., de Wit E., Havekes L.M. Vastatins inhibit cholesterol ester accumulation in human monocyte-derived macrophages. Arterioscler Thromb. 11:1991;146.
111. Bernini F., Didoni G., Bonfadini G., Bellosta S., Fumagalli R. Requirement for mevalonate in acetylated LDL induction of cholesterol esterification in macrophages. Atherosclerosis. 104:1993;19.
112. Bellosta S., Canavesi M., Via D., Pfister P., Fumagalli R., Paoletti R., Bernini F. HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages. Arterioscler Thromb Vasc Biol. 18:1998;1671.
113. Colli S., Eligini S., Lalli M., Camera M., Paoletti R., Tremoli E. Vastatins inhibit tissue factor in human macrophages:a novel mechanism of protection against atherothrombosis. Arterioscler Thromb Vasc Biol. 17:1997;265.
114. Camera M., Gaviraghi M., Tremoli E. Fluvastatin inhibits TNFα- and LPS-induced c-Rel/p65 nuclear translocation and tissue factor expression in human endothelial cells. Atherosclerosis. 134:1997;197. Abstract.
115. Ferro D., Basili S., Alessandri C., Mantovani B., Cordova C., Violi F. Simvastatin reduces monocyte-tissue factor expression in type IIa hypercholesterolemia. Lancet. 350:1997;1222.